Louisiana HB870: INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

What the bill says

An act To enact R.S. 22:1060.9, relative to health insurance; to establish requirements for formulary placement and cost-sharing obligations for specific generic drugs and biosimilars; to prohibit certain utilization management practices; to provide definitions; and to provide for related matters.

From the introduced text:

AN ACT To enact R.S. 22:1060.9, relative to health insurance; to establish requirements for formulary placement and cost-sharing obligations for specific generic drugs and biosimilars; to prohibit certain utilization management practices; to provide definitions; and to provide for related matters. Be it enacted by the Legislature of Louisiana: Section 1. R.S. 22:1060.9 is hereby enacted to read as follows: §1060.9. Formulary placement; coverage requirements for certain generic drugs and biosimilars A. For purposes of this Section, the following terms have the meanings ascribed to them in this Subsection: (1) "Biosimilar" means a biological product that is licensed by the United States Food and Drug Administration as being highly similar to a reference product, with only minor differences in clinically inactive components, and is marketed pursuant to such licensure, ensuring there are no clinically meaningful differences in purity, potency, or safety between the two products. (2) "Generic drug" means a drug that contains the same active ingredient formulation as a brand name drug and has been approved by the United States Food and Drug Administration as a generic version of a reference listed drug, and is marketed pursuant to such approval. Page 1 of CODING: Words in struck through type are deletions from existing law; words underscored are additions. HLS 26RS-1085 ORIGINAL HB NO. (3) "Reference listed drug" means an approved …

Read the full official text

Sponsors

• Turner, Christopher (R, 12) · primary sponsor

Latest actions

1. June 12, 2026: Effective date: 08/01/2026.
2. June 12, 2026: Signed by the Governor. Becomes Act No. 907.
3. June 2, 2026: Sent to the Governor for executive approval.
4. June 1, 2026: Signed by the President of the Senate.
5. June 1, 2026: Enrolled and signed by the Speaker of the House.
6. May 31, 2026: Notice of Senate adoption of Conference Committee Report.
7. May 31, 2026: Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.
8. May 31, 2026: Notice House adopted the Conference Committee Report.
9. May 31, 2026: Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.
10. May 29, 2026: Scheduled for floor debate on 05/312026.

Votes

• Senate Vote on HB 870, ADOPT (#1603) (May 31, 2026): 36 yea, 0 nay, passed
• House Vote on HB 870, ADOPT CONFERENCE REPORT (#1790) (May 31, 2026): 94 yea, 0 nay, passed
• House Vote on HB 870, REJECT SENATE AMENDMENTS (#1490) (May 26, 2026): 99 yea, 0 nay, passed
• Senate Vote on HB 870, FINAL PASSAGE (#1021) (May 19, 2026): 33 yea, 0 nay, passed
• House Vote on HB 870, FINAL PASSAGE (#466) (April 13, 2026): 96 yea, 0 nay, passed

Common questions

What is HB870?

HB870 is a bill in the Louisiana Legislature (2026 Regular Session): INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note).

What does HB870 do?

In its own words: An act To enact R.S. 22:1060.9, relative to health insurance; to establish requirements for formulary placement and cost-sharing obligations for specific generic drugs and biosimilars; to prohibit certain utilization management practices; to provide definitions; and to provide for related matters.

What is the status of HB870?

Signed into law as of June 12, 2026. Latest action: Effective date: 08/01/2026. (June 12, 2026).

Who sponsored HB870?

Turner, Christopher (R, 12).

Where is the official record for HB870?

On the Louisiana Legislature website: https://legis.la.gov/legis/BillInfo.aspx?s=26RS&b=HB870